***Background.*** The recent increase in community-associated (CA) multidrug-resistant (MDR) *E. coli* has been well described in adults, but not in children. Accordingly, we sought to identify risk factors for infection or colonization with MDR *E. coli* in children.

***Methods.*** We conducted a retrospective cohort study of children from birth through 18 years with *E. coli* cultured from extraintestinal specimens at our institution between January 1, 2012 to December 31, 2012. Clinical data were abstracted from medical records. Pansusceptible (PS) isolates were susceptible to all antibiotic classes, while MDR isolates were resistant to at least 3 different antibiotic classes, excluding ampicillin. Risk factors for MDR *E. coli* were determined using univariable and multivariable logistic regression.

***Results.*** 368 children (mean age 8.3 years) each contributed 1 isolate. Most isolates were CA (82%), and from females (86%), outpatients (86%), and urine (90%). The distribution of resistance phenotypes was 53% PS, 35% resistant to various agents but not MDR, 13% MDR, and 3% resistant to extended spectrum cephalosporins.

In univariable analysis, features significantly associated with having an MDR strain were healthcare acquisition, cerebrospinal or genitourinary (GU) tract anomaly, invasive procedure within the prior 90 days, presence of an invasive device, history of international travel, hospitalization in the preceding year, and antibiotic use within the preceding 3 months. In multivariable analysis, GU tract anomaly (OR 3.87 \[95% CI 1.49-10.07\]), presence of an invasive device (OR 2.90 \[95% CI 1.01 -- 8.35\]) and prior hospitalization (OR 2.57 \[95% CI 1.17 -- 5.66\]) were significantly associated with MDR*.* Among the subset of patients with community-associated *E. coli* (n= 297), multivariable risk factors for MDR were GU tract anomaly (OR 5.53 \[95%CI 1.57-19.51\]), and hospitalization in the prior year (OR 2.83 \[95%CI 1.12-7.18\]).

***Conclusion.*** In this cohort of children in the US Midwest, community-associated MDR *E. coli* was not common among healthy children, but was significantly associated with GU anomalies and prior hospitalization. Pediatric providers should be aware of these risk factors when prescribing empiric antimicrobial therapy for *E. coli*.
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